tiprankstipranks
Trending News
More News >
Promising Clinical Data and Strategic Milestones Drive Buy Rating for Aligos Therapeutics
PremiumRatingsPromising Clinical Data and Strategic Milestones Drive Buy Rating for Aligos Therapeutics
1M ago
Aligos Therapeutics files to sell 6.25M shares of common stock for holders
Premium
The Fly
Aligos Therapeutics files to sell 6.25M shares of common stock for holders
2M ago
Aligos Therapeutics presents positive data at APASL2025
Premium
The Fly
Aligos Therapeutics presents positive data at APASL2025
2M ago
Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
PremiumThe FlyAligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
2M ago
Aligos Therapeutics Advances Pipeline Amid Financial Challenges
Premium
Company Announcements
Aligos Therapeutics Advances Pipeline Amid Financial Challenges
2M ago
Aligos Therapeutics reports Q4 EPS ($13.08) vs ($5.50) last year
Premium
The Fly
Aligos Therapeutics reports Q4 EPS ($13.08) vs ($5.50) last year
2M ago
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
PremiumThe FlyAligos Therapeutics announces inducement grants under Nasdaq listing rule
5M ago
Aligos Therapeutics down 8% after data presented at The Liver Meeting
Premium
The Fly
Aligos Therapeutics down 8% after data presented at The Liver Meeting
6M ago
Aligos Therapeutics trading resumes
Premium
The Fly
Aligos Therapeutics trading resumes
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100